Comparison of skin cancer awareness and sun protection behaviours between renal transplant recipients and patients with glomerular disease treated with immunosuppressants

Publication Name

Nephrology

Abstract

Background: There is no previous study that compare skin cancer awareness and photoprotective behaviours between renal transplant recipients (RTR) and patients with glomerular disease (GD). Objectives/Methods: Sixty-one RTR and 51 patients with GD were given a self-reported questionnaire to evaluate skin cancer awareness and photoprotective behaviours in this cross-sectional study. The former group received a formal education on skin cancer and the latter an informal session prior to immunosuppressant use. Results: Ninety-three percent (n = 57) of RTRs and 88% (n = 45) of patients with GD responded to the survey. Majority of participants from both groups were aware that ultraviolet radiation could play a role in the occurrence of skin cancers and the awareness increased in participants with higher education (odds ratio [OR] = 1.50, 95% confidence interval [CI] = 1.15-1.95, P =.003). Ninety-eight percent vs 71% were aware that immunosuppressants can increase the risk of developing cancer (P <.001) and higher awareness was noted in younger participants (OR = 0.92, 95% CI = 0.87-0.97, P =.003). Suboptimal photoprotective behaviours (sun avoidance, sunscreen usage and sun-protective clothing) were noted in both cohorts and slightly lower sun protection rates were reported in RTR when compared with patients having GD. The level of sun protective measures in RTR based on high, moderate and minimal use of photoprotective measures were 21%, 46% and 33%, respectively. In terms of patients with GD, the latter practices were 13%, 50% and 37%, respectively (P =.560). Higher educational status was significantly associated with better sunscreen usage in RTR (P =.017) whereas this finding was not observed in patients with GD. Conclusion: Patients with GD and RTR should have formal education on the risks of skin cancers before starting immunosuppressants. Follow-up education and surveillance is required to improve skin protective practices in these patients.

Open Access Status

This publication is not available as open access

Volume

26

Issue

4

First Page

294

Last Page

302

Funding Sponsor

Griffith University

Share

COinS
 

Link to publisher version (DOI)

http://dx.doi.org/10.1111/nep.13840